Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|June 1, 2026
A scissor-guided single-cell framework defines a macrophage-derived risk score for prognostic and immunotherapy stratification in lung adenocarcinomaYueyue Shi, Linyue Hai, Guoqing Hou, et al.
Journal of Oleo Science|May 26, 2024
Exploring the Anticancer Properties of Sakuranin Flavanone in Human Oropharyngeal Squamous Carcinoma Cells by Studying Its Effects on Caspase-driven Apoptosis, Mitochondrial Membrane Potential (MMP) Loss, Cell Migratory and Invasiveness and m-TOR/PI3K/AKT Signalling PathwayFanyong Kong, Jie Zhai, Yueyue Shi, et al.
Journal of Hazardous Materials|June 28, 2023
Degradation of sulfamethoxazole by super-hydrophilic MoS2 sponge co-catalytic Fenton: Enhancing Fe2+/Fe3+ cycle and mass transferChun Xiao, Yongyou Hu, Qitian Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2006
HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cellsMichael J Ross, Cheng Fan, Michael D Ross, et al.
Cell & Bioscience|June 30, 2021
ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12Lili Li, Yueyue Shi, Sirui Li, et al.
Cellular & Molecular Immunology|November 16, 2021
Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagensWancheng Liu, Meiling Gao, Lili Li, et al.
Cell Cycle (Georgetown, Tex.)|February 15, 2022
CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cellsXiaoxi Zhang, Yunxia Sun, Siyao Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2021
Rational design of ASCT2 inhibitors using an integrated experimental-computational approachRachel-Ann A Garibsingh, Elias Ndaru, Alisa A Garaeva, et al.
Communications Biology|October 13, 2023
DNA damage induced by CDK4 and CDK6 blockade triggers anti-tumor immune responses through cGAS-STING pathwayHuimin Fan, Wancheng Liu, Yanqiong Zeng, et al.
Frontiers in Immunology|August 5, 2026
J2R/F4L deleted oncolytic vaccinia virus synergizes with tumor specific killer (ELANE) promotes antitumor immunity with superior safetyYu Huang, Liming Wang, Shan Mei, et al.
Pageof 5